Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
1,179
archived clinical trials in
Anxiety

Effectiveness of School-Based Cognitive Behavioral Therapy in Preventing Depression in Young Adolescents
Preventing Depression in School Children
Status: Enrolling
Updated:  9/9/2015
Univ of Pennsylvania
414
mi
from 43215
Philadelphia, PA
Effectiveness of School-Based Cognitive Behavioral Therapy in Preventing Depression in Young Adolescents
Preventing Depression in School Children
Status: Enrolling
Updated: 9/9/2015
Univ of Pennsylvania
414
mi
from 43215
Philadelphia, PA
Click here to add this to my saved trials
Acceptance and Commitment Therapy (ACT) for OEF/OIF Veterans
Initial Randomized Controlled Trial of Acceptance and Commitment Therapy (ACT) for Distress and Impairment in OEF/OIF Veterans
Status: Enrolling
Updated:  9/18/2015
Togus VA Medical Center
741
mi
from 43215
Augusta, ME
Acceptance and Commitment Therapy (ACT) for OEF/OIF Veterans
Initial Randomized Controlled Trial of Acceptance and Commitment Therapy (ACT) for Distress and Impairment in OEF/OIF Veterans
Status: Enrolling
Updated: 9/18/2015
Togus VA Medical Center
741
mi
from 43215
Augusta, ME
Click here to add this to my saved trials
Acceptance and Commitment Therapy (ACT) for OEF/OIF Veterans
Initial Randomized Controlled Trial of Acceptance and Commitment Therapy (ACT) for Distress and Impairment in OEF/OIF Veterans
Status: Enrolling
Updated:  9/18/2015
Durham VA Medical Center
351
mi
from 43215
Durham, NC
Acceptance and Commitment Therapy (ACT) for OEF/OIF Veterans
Initial Randomized Controlled Trial of Acceptance and Commitment Therapy (ACT) for Distress and Impairment in OEF/OIF Veterans
Status: Enrolling
Updated: 9/18/2015
Durham VA Medical Center
351
mi
from 43215
Durham, NC
Click here to add this to my saved trials
Acceptance and Commitment Therapy (ACT) for OEF/OIF Veterans
Initial Randomized Controlled Trial of Acceptance and Commitment Therapy (ACT) for Distress and Impairment in OEF/OIF Veterans
Status: Enrolling
Updated:  9/18/2015
Cincinnati VA Medical Center
97
mi
from 43215
Cincinnati, OH
Acceptance and Commitment Therapy (ACT) for OEF/OIF Veterans
Initial Randomized Controlled Trial of Acceptance and Commitment Therapy (ACT) for Distress and Impairment in OEF/OIF Veterans
Status: Enrolling
Updated: 9/18/2015
Cincinnati VA Medical Center
97
mi
from 43215
Cincinnati, OH
Click here to add this to my saved trials
Acceptance and Commitment Therapy (ACT) for OEF/OIF Veterans
Initial Randomized Controlled Trial of Acceptance and Commitment Therapy (ACT) for Distress and Impairment in OEF/OIF Veterans
Status: Enrolling
Updated:  9/18/2015
VA Puget Sound Health System
2006
mi
from 43215
Seattle, WA
Acceptance and Commitment Therapy (ACT) for OEF/OIF Veterans
Initial Randomized Controlled Trial of Acceptance and Commitment Therapy (ACT) for Distress and Impairment in OEF/OIF Veterans
Status: Enrolling
Updated: 9/18/2015
VA Puget Sound Health System
2006
mi
from 43215
Seattle, WA
Click here to add this to my saved trials
Acceptance and Commitment Therapy (ACT) for OEF/OIF Veterans
Initial Randomized Controlled Trial of Acceptance and Commitment Therapy (ACT) for Distress and Impairment in OEF/OIF Veterans
Status: Enrolling
Updated:  9/18/2015
VA San Diego Healthcare System
1957
mi
from 43215
La Jolla, CA
Acceptance and Commitment Therapy (ACT) for OEF/OIF Veterans
Initial Randomized Controlled Trial of Acceptance and Commitment Therapy (ACT) for Distress and Impairment in OEF/OIF Veterans
Status: Enrolling
Updated: 9/18/2015
VA San Diego Healthcare System
1957
mi
from 43215
La Jolla, CA
Click here to add this to my saved trials
Acceptance and Commitment Therapy (ACT) for OEF/OIF Veterans
Initial Randomized Controlled Trial of Acceptance and Commitment Therapy (ACT) for Distress and Impairment in OEF/OIF Veterans
Status: Enrolling
Updated:  9/18/2015
Walter Reed National Military Medical Center
328
mi
from 43215
Washington,
Acceptance and Commitment Therapy (ACT) for OEF/OIF Veterans
Initial Randomized Controlled Trial of Acceptance and Commitment Therapy (ACT) for Distress and Impairment in OEF/OIF Veterans
Status: Enrolling
Updated: 9/18/2015
Walter Reed National Military Medical Center
328
mi
from 43215
Washington,
Click here to add this to my saved trials
Controlled Substance Treatment Agreements in an Internal Medicine Residents' Clinic
Controlled Substance Treatment Agreements in an Internal Medicine Residents' Clinic
Status: Enrolling
Updated:  9/22/2015
Ohio State University
2
mi
from 43215
Columbus, OH
Controlled Substance Treatment Agreements in an Internal Medicine Residents' Clinic
Controlled Substance Treatment Agreements in an Internal Medicine Residents' Clinic
Status: Enrolling
Updated: 9/22/2015
Ohio State University
2
mi
from 43215
Columbus, OH
Click here to add this to my saved trials
Educational Brochure in Preparing Patients With Gastric Cancer and Their Caregivers for Recovery After Surgery
Pilot Study of an Educational Brochure to Prepare Patients and Informal Caregivers for Recovery Following Gastrectomy
Status: Enrolling
Updated:  9/23/2015
City of Hope Medical Center
1955
mi
from 43215
Duarte, CA
Educational Brochure in Preparing Patients With Gastric Cancer and Their Caregivers for Recovery After Surgery
Pilot Study of an Educational Brochure to Prepare Patients and Informal Caregivers for Recovery Following Gastrectomy
Status: Enrolling
Updated: 9/23/2015
City of Hope Medical Center
1955
mi
from 43215
Duarte, CA
Click here to add this to my saved trials
Study of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
A Multicenter, Randomized, Double-Blind, Placebo and Escitalopram Controlled Trial of the Safety and Efficacy of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
Status: Enrolling
Updated:  9/23/2015
Pivotal Research Centers
1650
mi
from 43215
Mesa, AZ
Study of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
A Multicenter, Randomized, Double-Blind, Placebo and Escitalopram Controlled Trial of the Safety and Efficacy of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
Status: Enrolling
Updated: 9/23/2015
Pivotal Research Centers
1650
mi
from 43215
Mesa, AZ
Click here to add this to my saved trials
Study of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
A Multicenter, Randomized, Double-Blind, Placebo and Escitalopram Controlled Trial of the Safety and Efficacy of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
Status: Enrolling
Updated:  9/23/2015
Pacific Clinical Research Medical Group
1972
mi
from 43215
Burbank, CA
Study of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
A Multicenter, Randomized, Double-Blind, Placebo and Escitalopram Controlled Trial of the Safety and Efficacy of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
Status: Enrolling
Updated: 9/23/2015
Pacific Clinical Research Medical Group
1972
mi
from 43215
Burbank, CA
Click here to add this to my saved trials
Study of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
A Multicenter, Randomized, Double-Blind, Placebo and Escitalopram Controlled Trial of the Safety and Efficacy of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
Status: Enrolling
Updated:  9/23/2015
Us Clinical Research Centers, Llc
1965
mi
from 43215
Costa Mesa, CA
Study of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
A Multicenter, Randomized, Double-Blind, Placebo and Escitalopram Controlled Trial of the Safety and Efficacy of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
Status: Enrolling
Updated: 9/23/2015
Us Clinical Research Centers, Llc
1965
mi
from 43215
Costa Mesa, CA
Click here to add this to my saved trials
Study of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
A Multicenter, Randomized, Double-Blind, Placebo and Escitalopram Controlled Trial of the Safety and Efficacy of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
Status: Enrolling
Updated:  9/23/2015
Pacific Institute for Medical Research Inc
1982
mi
from 43215
Los Angeles, CA
Study of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
A Multicenter, Randomized, Double-Blind, Placebo and Escitalopram Controlled Trial of the Safety and Efficacy of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
Status: Enrolling
Updated: 9/23/2015
Pacific Institute for Medical Research Inc
1982
mi
from 43215
Los Angeles, CA
Click here to add this to my saved trials
Study of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
A Multicenter, Randomized, Double-Blind, Placebo and Escitalopram Controlled Trial of the Safety and Efficacy of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
Status: Enrolling
Updated:  9/23/2015
Affiliated Research Institute
1948
mi
from 43215
San Diego, CA
Study of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
A Multicenter, Randomized, Double-Blind, Placebo and Escitalopram Controlled Trial of the Safety and Efficacy of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
Status: Enrolling
Updated: 9/23/2015
Affiliated Research Institute
1948
mi
from 43215
San Diego, CA
Click here to add this to my saved trials
Study of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
A Multicenter, Randomized, Double-Blind, Placebo and Escitalopram Controlled Trial of the Safety and Efficacy of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
Status: Enrolling
Updated:  9/23/2015
Pacific Clinical Research Medical Group
1940
mi
from 43215
Upland, CA
Study of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
A Multicenter, Randomized, Double-Blind, Placebo and Escitalopram Controlled Trial of the Safety and Efficacy of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
Status: Enrolling
Updated: 9/23/2015
Pacific Clinical Research Medical Group
1940
mi
from 43215
Upland, CA
Click here to add this to my saved trials
Study of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
A Multicenter, Randomized, Double-Blind, Placebo and Escitalopram Controlled Trial of the Safety and Efficacy of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
Status: Enrolling
Updated:  9/23/2015
Radiant Research, Inc.
1153
mi
from 43215
Denver, CO
Study of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
A Multicenter, Randomized, Double-Blind, Placebo and Escitalopram Controlled Trial of the Safety and Efficacy of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
Status: Enrolling
Updated: 9/23/2015
Radiant Research, Inc.
1153
mi
from 43215
Denver, CO
Click here to add this to my saved trials
Study of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
A Multicenter, Randomized, Double-Blind, Placebo and Escitalopram Controlled Trial of the Safety and Efficacy of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
Status: Enrolling
Updated:  9/23/2015
University of Connecticut Health Center
545
mi
from 43215
Farmington, CT
Study of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
A Multicenter, Randomized, Double-Blind, Placebo and Escitalopram Controlled Trial of the Safety and Efficacy of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
Status: Enrolling
Updated: 9/23/2015
University of Connecticut Health Center
545
mi
from 43215
Farmington, CT
Click here to add this to my saved trials
Study of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
A Multicenter, Randomized, Double-Blind, Placebo and Escitalopram Controlled Trial of the Safety and Efficacy of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
Status: Enrolling
Updated:  9/23/2015
Comprehensive Psychiatric Care
582
mi
from 43215
Norwich, CT
Study of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
A Multicenter, Randomized, Double-Blind, Placebo and Escitalopram Controlled Trial of the Safety and Efficacy of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
Status: Enrolling
Updated: 9/23/2015
Comprehensive Psychiatric Care
582
mi
from 43215
Norwich, CT
Click here to add this to my saved trials
Study of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
A Multicenter, Randomized, Double-Blind, Placebo and Escitalopram Controlled Trial of the Safety and Efficacy of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
Status: Enrolling
Updated:  9/23/2015
Meridien Research
789
mi
from 43215
Brooksville, FL
Study of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
A Multicenter, Randomized, Double-Blind, Placebo and Escitalopram Controlled Trial of the Safety and Efficacy of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
Status: Enrolling
Updated: 9/23/2015
Meridien Research
789
mi
from 43215
Brooksville, FL
Click here to add this to my saved trials
Study of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
A Multicenter, Randomized, Double-Blind, Placebo and Escitalopram Controlled Trial of the Safety and Efficacy of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
Status: Enrolling
Updated:  9/23/2015
Clinical Neuroscience Solutions, Inc.
673
mi
from 43215
Jacksonville, FL
Study of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
A Multicenter, Randomized, Double-Blind, Placebo and Escitalopram Controlled Trial of the Safety and Efficacy of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
Status: Enrolling
Updated: 9/23/2015
Clinical Neuroscience Solutions, Inc.
673
mi
from 43215
Jacksonville, FL
Click here to add this to my saved trials
Study of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
A Multicenter, Randomized, Double-Blind, Placebo and Escitalopram Controlled Trial of the Safety and Efficacy of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
Status: Enrolling
Updated:  9/23/2015
Comprehensive Neuroscience, Inc.
837
mi
from 43215
St Petersburg, FL
Study of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
A Multicenter, Randomized, Double-Blind, Placebo and Escitalopram Controlled Trial of the Safety and Efficacy of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
Status: Enrolling
Updated: 9/23/2015
Comprehensive Neuroscience, Inc.
837
mi
from 43215
St Petersburg, FL
Click here to add this to my saved trials
Study of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
A Multicenter, Randomized, Double-Blind, Placebo and Escitalopram Controlled Trial of the Safety and Efficacy of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
Status: Enrolling
Updated:  9/23/2015
Stedman Clinical Trials
821
mi
from 43215
Tampa, FL
Study of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
A Multicenter, Randomized, Double-Blind, Placebo and Escitalopram Controlled Trial of the Safety and Efficacy of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
Status: Enrolling
Updated: 9/23/2015
Stedman Clinical Trials
821
mi
from 43215
Tampa, FL
Click here to add this to my saved trials
Study of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
A Multicenter, Randomized, Double-Blind, Placebo and Escitalopram Controlled Trial of the Safety and Efficacy of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
Status: Enrolling
Updated:  9/23/2015
Janus Center for Psychiatric Research
927
mi
from 43215
West Palm Beach, FL
Study of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
A Multicenter, Randomized, Double-Blind, Placebo and Escitalopram Controlled Trial of the Safety and Efficacy of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
Status: Enrolling
Updated: 9/23/2015
Janus Center for Psychiatric Research
927
mi
from 43215
West Palm Beach, FL
Click here to add this to my saved trials
Study of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
A Multicenter, Randomized, Double-Blind, Placebo and Escitalopram Controlled Trial of the Safety and Efficacy of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
Status: Enrolling
Updated:  9/23/2015
Carman Research
428
mi
from 43215
Smyrna, GA
Study of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
A Multicenter, Randomized, Double-Blind, Placebo and Escitalopram Controlled Trial of the Safety and Efficacy of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
Status: Enrolling
Updated: 9/23/2015
Carman Research
428
mi
from 43215
Smyrna, GA
Click here to add this to my saved trials
Study of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
A Multicenter, Randomized, Double-Blind, Placebo and Escitalopram Controlled Trial of the Safety and Efficacy of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
Status: Enrolling
Updated:  9/23/2015
Indiana University School of Medicine
166
mi
from 43215
Indianapolis, IN
Study of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
A Multicenter, Randomized, Double-Blind, Placebo and Escitalopram Controlled Trial of the Safety and Efficacy of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
Status: Enrolling
Updated: 9/23/2015
Indiana University School of Medicine
166
mi
from 43215
Indianapolis, IN
Click here to add this to my saved trials
Study of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
A Multicenter, Randomized, Double-Blind, Placebo and Escitalopram Controlled Trial of the Safety and Efficacy of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
Status: Enrolling
Updated:  9/23/2015
Alpine Clinic
205
mi
from 43215
Lafayette, IN
Study of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
A Multicenter, Randomized, Double-Blind, Placebo and Escitalopram Controlled Trial of the Safety and Efficacy of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
Status: Enrolling
Updated: 9/23/2015
Alpine Clinic
205
mi
from 43215
Lafayette, IN
Click here to add this to my saved trials
Study of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
A Multicenter, Randomized, Double-Blind, Placebo and Escitalopram Controlled Trial of the Safety and Efficacy of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
Status: Enrolling
Updated:  9/23/2015
Cientifica, Inc. At Prairie View Inc.
999
mi
from 43215
Newton, KA
Study of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
A Multicenter, Randomized, Double-Blind, Placebo and Escitalopram Controlled Trial of the Safety and Efficacy of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
Status: Enrolling
Updated: 9/23/2015
Cientifica, Inc. At Prairie View Inc.
999
mi
from 43215
Newton, KA
Click here to add this to my saved trials
Study of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
A Multicenter, Randomized, Double-Blind, Placebo and Escitalopram Controlled Trial of the Safety and Efficacy of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
Status: Enrolling
Updated:  9/23/2015
Ctt, Inc.
622
mi
from 43215
Prairie Village, KA
Study of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
A Multicenter, Randomized, Double-Blind, Placebo and Escitalopram Controlled Trial of the Safety and Efficacy of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
Status: Enrolling
Updated: 9/23/2015
Ctt, Inc.
622
mi
from 43215
Prairie Village, KA
Click here to add this to my saved trials
Study of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
A Multicenter, Randomized, Double-Blind, Placebo and Escitalopram Controlled Trial of the Safety and Efficacy of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
Status: Enrolling
Updated:  9/23/2015
J. Gary Booker, MD APMC
788
mi
from 43215
Shreveport, LA
Study of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
A Multicenter, Randomized, Double-Blind, Placebo and Escitalopram Controlled Trial of the Safety and Efficacy of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
Status: Enrolling
Updated: 9/23/2015
J. Gary Booker, MD APMC
788
mi
from 43215
Shreveport, LA
Click here to add this to my saved trials
Study of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
A Multicenter, Randomized, Double-Blind, Placebo and Escitalopram Controlled Trial of the Safety and Efficacy of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
Status: Enrolling
Updated:  9/23/2015
Pharmasite Research
337
mi
from 43215
Baltimore, MD
Study of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
A Multicenter, Randomized, Double-Blind, Placebo and Escitalopram Controlled Trial of the Safety and Efficacy of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
Status: Enrolling
Updated: 9/23/2015
Pharmasite Research
337
mi
from 43215
Baltimore, MD
Click here to add this to my saved trials
Study of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
A Multicenter, Randomized, Double-Blind, Placebo and Escitalopram Controlled Trial of the Safety and Efficacy of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
Status: Enrolling
Updated:  9/23/2015
Capital Clinical Research Associates
320
mi
from 43215
Rockville, MD
Study of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
A Multicenter, Randomized, Double-Blind, Placebo and Escitalopram Controlled Trial of the Safety and Efficacy of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
Status: Enrolling
Updated: 9/23/2015
Capital Clinical Research Associates
320
mi
from 43215
Rockville, MD
Click here to add this to my saved trials
Study of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
A Multicenter, Randomized, Double-Blind, Placebo and Escitalopram Controlled Trial of the Safety and Efficacy of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
Status: Enrolling
Updated:  9/23/2015
Boston Clinical Trials, INC.
643
mi
from 43215
Boston, MA
Study of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
A Multicenter, Randomized, Double-Blind, Placebo and Escitalopram Controlled Trial of the Safety and Efficacy of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
Status: Enrolling
Updated: 9/23/2015
Boston Clinical Trials, INC.
643
mi
from 43215
Boston, MA
Click here to add this to my saved trials
Study of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
A Multicenter, Randomized, Double-Blind, Placebo and Escitalopram Controlled Trial of the Safety and Efficacy of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
Status: Enrolling
Updated:  9/23/2015
Regions Hospital
617
mi
from 43215
St. Paul, MN
Study of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
A Multicenter, Randomized, Double-Blind, Placebo and Escitalopram Controlled Trial of the Safety and Efficacy of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
Status: Enrolling
Updated: 9/23/2015
Regions Hospital
617
mi
from 43215
St. Paul, MN
Click here to add this to my saved trials
Study of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
A Multicenter, Randomized, Double-Blind, Placebo and Escitalopram Controlled Trial of the Safety and Efficacy of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
Status: Enrolling
Updated:  9/23/2015
Neurobehavioral Research, Inc.
491
mi
from 43215
Cedarhurst, NY
Study of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
A Multicenter, Randomized, Double-Blind, Placebo and Escitalopram Controlled Trial of the Safety and Efficacy of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
Status: Enrolling
Updated: 9/23/2015
Neurobehavioral Research, Inc.
491
mi
from 43215
Cedarhurst, NY
Click here to add this to my saved trials
Study of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
A Multicenter, Randomized, Double-Blind, Placebo and Escitalopram Controlled Trial of the Safety and Efficacy of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
Status: Enrolling
Updated:  9/23/2015
Bioscience Research, Llc
478
mi
from 43215
New York, NY
Study of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
A Multicenter, Randomized, Double-Blind, Placebo and Escitalopram Controlled Trial of the Safety and Efficacy of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
Status: Enrolling
Updated: 9/23/2015
Bioscience Research, Llc
478
mi
from 43215
New York, NY
Click here to add this to my saved trials
Study of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
A Multicenter, Randomized, Double-Blind, Placebo and Escitalopram Controlled Trial of the Safety and Efficacy of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
Status: Enrolling
Updated:  9/23/2015
Fieve Clinical Services Inc
480
mi
from 43215
New York, NY
Study of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
A Multicenter, Randomized, Double-Blind, Placebo and Escitalopram Controlled Trial of the Safety and Efficacy of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
Status: Enrolling
Updated: 9/23/2015
Fieve Clinical Services Inc
480
mi
from 43215
New York, NY
Click here to add this to my saved trials
Study of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
A Multicenter, Randomized, Double-Blind, Placebo and Escitalopram Controlled Trial of the Safety and Efficacy of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
Status: Enrolling
Updated:  9/23/2015
Social Psychiatry Research Institute
480
mi
from 43215
New York, NY
Study of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
A Multicenter, Randomized, Double-Blind, Placebo and Escitalopram Controlled Trial of the Safety and Efficacy of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
Status: Enrolling
Updated: 9/23/2015
Social Psychiatry Research Institute
480
mi
from 43215
New York, NY
Click here to add this to my saved trials
Study of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
A Multicenter, Randomized, Double-Blind, Placebo and Escitalopram Controlled Trial of the Safety and Efficacy of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
Status: Enrolling
Updated:  9/23/2015
Behavioral Medical Research of Staten Island
473
mi
from 43215
Staten Island, NY
Study of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
A Multicenter, Randomized, Double-Blind, Placebo and Escitalopram Controlled Trial of the Safety and Efficacy of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
Status: Enrolling
Updated: 9/23/2015
Behavioral Medical Research of Staten Island
473
mi
from 43215
Staten Island, NY
Click here to add this to my saved trials
Study of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
A Multicenter, Randomized, Double-Blind, Placebo and Escitalopram Controlled Trial of the Safety and Efficacy of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
Status: Enrolling
Updated:  9/23/2015
Richmond Behavioral Associates
468
mi
from 43215
Staten Island, NY
Study of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
A Multicenter, Randomized, Double-Blind, Placebo and Escitalopram Controlled Trial of the Safety and Efficacy of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
Status: Enrolling
Updated: 9/23/2015
Richmond Behavioral Associates
468
mi
from 43215
Staten Island, NY
Click here to add this to my saved trials
Study of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
A Multicenter, Randomized, Double-Blind, Placebo and Escitalopram Controlled Trial of the Safety and Efficacy of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
Status: Enrolling
Updated:  9/23/2015
North Carolina Neuropsychiatry, Pa
351
mi
from 43215
Charlotte, NC
Study of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
A Multicenter, Randomized, Double-Blind, Placebo and Escitalopram Controlled Trial of the Safety and Efficacy of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
Status: Enrolling
Updated: 9/23/2015
North Carolina Neuropsychiatry, Pa
351
mi
from 43215
Charlotte, NC
Click here to add this to my saved trials
Study of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
A Multicenter, Randomized, Double-Blind, Placebo and Escitalopram Controlled Trial of the Safety and Efficacy of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
Status: Enrolling
Updated:  9/23/2015
Medark Clinical Research
300
mi
from 43215
Morganton, NC
Study of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
A Multicenter, Randomized, Double-Blind, Placebo and Escitalopram Controlled Trial of the Safety and Efficacy of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
Status: Enrolling
Updated: 9/23/2015
Medark Clinical Research
300
mi
from 43215
Morganton, NC
Click here to add this to my saved trials
Study of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
A Multicenter, Randomized, Double-Blind, Placebo and Escitalopram Controlled Trial of the Safety and Efficacy of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
Status: Enrolling
Updated:  9/23/2015
Psychiatry And Clinical Research
372
mi
from 43215
Raleigh, NC
Study of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
A Multicenter, Randomized, Double-Blind, Placebo and Escitalopram Controlled Trial of the Safety and Efficacy of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
Status: Enrolling
Updated: 9/23/2015
Psychiatry And Clinical Research
372
mi
from 43215
Raleigh, NC
Click here to add this to my saved trials
Study of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
A Multicenter, Randomized, Double-Blind, Placebo and Escitalopram Controlled Trial of the Safety and Efficacy of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
Status: Enrolling
Updated:  9/23/2015
Community Research
92
mi
from 43215
Cincinnati, OH
Study of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
A Multicenter, Randomized, Double-Blind, Placebo and Escitalopram Controlled Trial of the Safety and Efficacy of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
Status: Enrolling
Updated: 9/23/2015
Community Research
92
mi
from 43215
Cincinnati, OH
Click here to add this to my saved trials
Study of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
A Multicenter, Randomized, Double-Blind, Placebo and Escitalopram Controlled Trial of the Safety and Efficacy of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
Status: Enrolling
Updated:  9/23/2015
Midwest Clinical Research Center
65
mi
from 43215
Dayton, OH
Study of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
A Multicenter, Randomized, Double-Blind, Placebo and Escitalopram Controlled Trial of the Safety and Efficacy of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
Status: Enrolling
Updated: 9/23/2015
Midwest Clinical Research Center
65
mi
from 43215
Dayton, OH
Click here to add this to my saved trials
Study of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
A Multicenter, Randomized, Double-Blind, Placebo and Escitalopram Controlled Trial of the Safety and Efficacy of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
Status: Enrolling
Updated:  9/23/2015
IPS Research Company
849
mi
from 43215
Oklahoma City, OK
Study of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
A Multicenter, Randomized, Double-Blind, Placebo and Escitalopram Controlled Trial of the Safety and Efficacy of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
Status: Enrolling
Updated: 9/23/2015
IPS Research Company
849
mi
from 43215
Oklahoma City, OK
Click here to add this to my saved trials
Study of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
A Multicenter, Randomized, Double-Blind, Placebo and Escitalopram Controlled Trial of the Safety and Efficacy of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
Status: Enrolling
Updated:  9/23/2015
University of Oklahoma Health Sciences Center
841
mi
from 43215
Oklahoma City, OK
Study of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
A Multicenter, Randomized, Double-Blind, Placebo and Escitalopram Controlled Trial of the Safety and Efficacy of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
Status: Enrolling
Updated: 9/23/2015
University of Oklahoma Health Sciences Center
841
mi
from 43215
Oklahoma City, OK
Click here to add this to my saved trials
Study of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
A Multicenter, Randomized, Double-Blind, Placebo and Escitalopram Controlled Trial of the Safety and Efficacy of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
Status: Enrolling
Updated:  9/23/2015
Oregon Center for Clinical Investigations, Inc. (OCCI, Inc.)
2044
mi
from 43215
Salem, OR
Study of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
A Multicenter, Randomized, Double-Blind, Placebo and Escitalopram Controlled Trial of the Safety and Efficacy of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
Status: Enrolling
Updated: 9/23/2015
Oregon Center for Clinical Investigations, Inc. (OCCI, Inc.)
2044
mi
from 43215
Salem, OR
Click here to add this to my saved trials
Study of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
A Multicenter, Randomized, Double-Blind, Placebo and Escitalopram Controlled Trial of the Safety and Efficacy of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
Status: Enrolling
Updated:  9/23/2015
Lehigh Valley Hospital
400
mi
from 43215
Allentown, PA
Study of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
A Multicenter, Randomized, Double-Blind, Placebo and Escitalopram Controlled Trial of the Safety and Efficacy of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
Status: Enrolling
Updated: 9/23/2015
Lehigh Valley Hospital
400
mi
from 43215
Allentown, PA
Click here to add this to my saved trials
Study of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
A Multicenter, Randomized, Double-Blind, Placebo and Escitalopram Controlled Trial of the Safety and Efficacy of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
Status: Enrolling
Updated:  9/23/2015
Rhode Island Mood & Memory Research Institute
621
mi
from 43215
East Providence, RI
Study of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
A Multicenter, Randomized, Double-Blind, Placebo and Escitalopram Controlled Trial of the Safety and Efficacy of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
Status: Enrolling
Updated: 9/23/2015
Rhode Island Mood & Memory Research Institute
621
mi
from 43215
East Providence, RI
Click here to add this to my saved trials
Study of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
A Multicenter, Randomized, Double-Blind, Placebo and Escitalopram Controlled Trial of the Safety and Efficacy of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
Status: Enrolling
Updated:  9/23/2015
Medical University of South Carolina
524
mi
from 43215
Charleston, SC
Study of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
A Multicenter, Randomized, Double-Blind, Placebo and Escitalopram Controlled Trial of the Safety and Efficacy of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
Status: Enrolling
Updated: 9/23/2015
Medical University of South Carolina
524
mi
from 43215
Charleston, SC
Click here to add this to my saved trials